ACT Oncology is a full-service clinical research organization (CRO) with North American coverage and the ability to support global programs. Our dedicated team of experts works with our Sponsors to optimize oncology drug research and bring new treatments to the market quickly and efficiently.
ACT Oncology personnel will be attending the American Society of Hematology (ASH) conference in New Orleans, Louisiana from 7-10 December 2013. Please contact Chris Ellis, Director of Business Development, at 917-940-6464 to arrange a meeting with our operational and management staff. http://www.hematology.org/Meetings/Annual-Meeting/
ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 20 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.